Dose-Response Relationship, Drug
"Dose-Response Relationship, Drug" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The relationship between the dose of an administered drug and the response of the organism to the drug.
Descriptor ID |
D004305
|
MeSH Number(s) |
G07.690.773.875 G07.690.936.500
|
Concept/Terms |
Dose-Response Relationship, Drug- Dose-Response Relationship, Drug
- Dose-Response Relationships, Drug
- Drug Dose-Response Relationship
- Drug Dose-Response Relationships
- Relationship, Drug Dose-Response
- Relationships, Drug Dose-Response
- Dose Response Relationship, Drug
|
Below are MeSH descriptors whose meaning is more general than "Dose-Response Relationship, Drug".
Below are MeSH descriptors whose meaning is more specific than "Dose-Response Relationship, Drug".
This graph shows the total number of publications written about "Dose-Response Relationship, Drug" by people in this website by year, and whether "Dose-Response Relationship, Drug" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 136 | 137 |
1996 | 0 | 142 | 142 |
1997 | 0 | 118 | 118 |
1998 | 0 | 140 | 140 |
1999 | 0 | 170 | 170 |
2000 | 0 | 205 | 205 |
2001 | 0 | 238 | 238 |
2002 | 1 | 336 | 337 |
2003 | 1 | 427 | 428 |
2004 | 2 | 427 | 429 |
2005 | 1 | 391 | 392 |
2006 | 3 | 366 | 369 |
2007 | 4 | 376 | 380 |
2008 | 0 | 326 | 326 |
2009 | 0 | 366 | 366 |
2010 | 1 | 295 | 296 |
2011 | 1 | 334 | 335 |
2012 | 3 | 336 | 339 |
2013 | 1 | 295 | 296 |
2014 | 1 | 331 | 332 |
2015 | 4 | 283 | 287 |
2016 | 3 | 300 | 303 |
2017 | 2 | 276 | 278 |
2018 | 8 | 269 | 277 |
2019 | 0 | 220 | 220 |
2020 | 4 | 164 | 168 |
2021 | 6 | 117 | 123 |
2022 | 0 | 16 | 16 |
2023 | 1 | 8 | 9 |
2024 | 5 | 67 | 72 |
2025 | 0 | 5 | 5 |
Below are the most recent publications written about "Dose-Response Relationship, Drug" by people in Profiles.
-
Allopregnanolone as an Adjunct Therapy to Midazolam is More Effective Than Midazolam Alone in Suppressing Soman-Induced Status Epilepticus in Male Rats. CNS Neurosci Ther. 2025 Mar; 31(3):e70215.
-
Biguanides antithetically regulate tumor properties by the dose-dependent mitochondrial reprogramming-driven c-Src pathway. Cell Rep Med. 2025 Feb 18; 6(2):101941.
-
Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I study. J Neurol. 2025 Jan 15; 272(2):137.
-
Comparing the efficacy of different proton pump inhibitor dosing regimens for the treatment of gastroesophageal reflux disease: a systematic review and meta-analysis. Dis Esophagus. 2025 Jan 07; 38(1).
-
Dexamethasone dose intensity does not impact outcomes in newly diagnosed multiple myeloma: a secondary SWOG analysis. Blood. 2025 Jan 02; 145(1):75-84.
-
Predictive factors for first dose reduction and interruption of lenvatinib after beginning of the standard dose in Japanese patients with thyroid cancer. Cancer Chemother Pharmacol. 2024 Dec 19; 95(1):8.
-
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression. J Affect Disord. 2025 Mar 01; 372:523-532.
-
High potency 3-carboxy-2-methylbenzofuran pendrin inhibitors as novel diuretics. Eur J Med Chem. 2025 Feb 05; 283:117133.
-
Pyrazinamide Safety, Efficacy, and Dosing for Treating Drug-Susceptible Pulmonary Tuberculosis: A Phase 3, Randomized Controlled Clinical Trial. Am J Respir Crit Care Med. 2024 Dec 01; 210(11):1358-1369.
-
Nanomolar activity of coumarin-3-thiosemicarbazones targeting Trypanosoma cruzi cruzain and the T. brucei cathepsin L-like protease. Eur J Med Chem. 2025 Feb 05; 283:117109.